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Abstract 
 
Background 
Psychiatric disorders have historically been classified using symptom information alone. With the advent             
of new technologies that allowed researchers to investigate brain mechanisms in a more direct manner,               
interest in not only the mechanistic rationale behind defined pathologies but also aetiology redefinition has               
greatly increased. This is particularly appealing for the field of personalised medicine, which searches for               
data-driven approaches to improve diagnosis, prognosis and treatment selection on an individual basis. 
 
Objective 
In the present article, we intend to systematically analyse the usage of functional MRI on both the                 
elucidation of psychiatric disease biotypes and the interpretation/validation of subtypes obtained via            
unsupervised learning techniques applied to symptom or biomarker data. 
 
Methods 
Using PubMed, we searched the existing literature for functional MRI applications to the obtention or               
interpretation/validation of psychiatric disease subtypes in humans. The PRISMA guidelines were applied to             
filter the retrieved studies, and the active learning framework ASReviews was applied for article prioritization. 
 
Results 
From the 20 studies that met the inclusion criteria, 5 used functional MRI data to interpret                
symptom-derived disease clusters, 4 used it for the interpretation of clusters derived from biomarker data               
other than fMRI itself, and 11 applied clustering techniques to fMRI directly. Major depression disorder and                
schizophrenia were the two most studied pathologies (35% and 30% of the retrieved studies, respectively),               
followed by ADHD (15%), psychosis (10%), autism disorder (5%), and the consequences of early violence               
(5%). No trans-diagnostic studies were retrieved. 
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Conclusions 
While interest in personalised medicine and data-driven disease subtyping is on the rise and psychiatry is                
not the exception, unsupervised analyses of functional MRI data are inconsistent to date, and much remains                
to be done in terms of gathering and centralising data, standardising pipelines and model validation, and                
method refinement. The usage of fMRI in the field of trans-diagnostic psychiatry, of great importance for the                 
aforementioned goals, remains vastly unexplored. 
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Introduction 
 
Psychiatric disease prevalence 
Psychiatric disorders have a long history of being classified based solely on their associated symptoms,               
with the first attempts of systematic analysis dating back as far as 1840. Since the introduction of the                  
Diagnostic Manual of Mental Disorders (DSM) back in 1952 ​[1]​, and most importantly since the inclusion of                 
operationalized criteria in 1978 in the DSM-III ​[2]​, statistics on discrete pathological entities and their               
combination began to accumulate, yielding the potential of understanding psychiatric epidemiology in a             
consistent way. The last version of the DSM manual (DSM-5), published in 2013, contains 297 discrete                
disorders categorised into 11 broad classes, grouped together by evidence of co-occurring symptoms.             
Current prevalence estimates indicate that, on average, more than one in six (17.6%) have experienced at                
least one common psychiatric disorder within the last year, and almost three in ten (29.2%) during the course                  
of their lifetime ​[3]​. In an attempt to assess both the severity of the disorders and the response after                   
individual treatment, several standardised symptom scores have been developed, including the Hamilton            
Depression Rating Scale (HAM-D) for Major Depression Disorder, and the Positive and Negative Syndrome              
Scale (PANSS) for Schizophrenia, among others. 
 
Heterogeneity and alternatives to symptom-based diagnosis 
Symptom and clinical information can be relatively easy to acquire, and their analysis can be useful to                 
understand the symptom prevalence in the population and assess the effectiveness of treatment at a broad                
scale ​[4]​. They do not, however, necessarily reflect anything about the underlying mechanisms causing those               
symptoms. Furthermore, given the complexity of the genetic and environmental factors at play, the same set                
of symptoms can arise from absolutely different causes, while the same biological causes may lead to                
different symptoms or phenotypes ​[5,6]​. This is particularly important when analyzing the response to              
treatment, where the outcome is very difficult to predict based on the symptoms alone, and response to                 
medication is vastly heterogeneous ​[7]​, being treatment-resistant variants of disease not uncommon. To             
name a few examples, current estimates indicate that about 30% and 34% of medicated patients diagnosed                
with depression and schizophrenia, respectively, do not respond to treatment even after trying two or more                
drugs ​[8,9]​. This can be interpreted as an indication of the underlying mechanistic heterogeneity of these                
symptom-defined disorders. In light of this concern and with the advantage of new technologies and an                
increasing amount of related data, several initiatives have embarked on the quest of finding data-driven               
mechanistic disease definitions that may aid the issue. One of the most important to date has been the                  
Research Domain Criteria (RDoC), which was introduced by the NIH in 2009 as a framework to guide                 
research projects in the understanding of mental disorders from a combination of different perspectives,              
including not only self-reported symptoms but also genomics, circuits, and behaviour, among others ​[10]​.              
The ideas behind these mechanistic-based classifications can not only expand our knowledge of mental              
disorders themselves and allow for biomarker-based classification but also aid in identifying the best              
treatments for individual patients whose overlapping symptoms have distinct aetiological causes, an idea that              
is very much in line with those of personalized medicine. 
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Functional MRI for disease subtyping 
The idea of using multivariate pattern analysis to unravel the aforementioned heterogeneity, and unveil              
subgroups of patients within already defined diseases is not new ​[10–12]​. However, the advent of massive                
biological related datasets (the so-called ​high-throughput ​biology​) in areas such as genomics,            
transcriptomics, and proteomics and the newly available techniques to study the brain in a non-invasive way,                
opened a whole new field of possibilities to study not only the underlying mechanisms of symptom-related                
clusters but to search for biologically defined subtypes of disease (or ​biotypes​) as well. Although initial hopes                 
were put on mainly genetics, over the years an increasing number of GWA studies has revealed that brain                  
disorders tend to be associated with a high number of genetic variants with very small effect sizes.                 
Furthermore, individual genetic alterations often overlap among symptom-defined diseases ​[13]​. While some            
progress in genetic biomarkers has been made using disease-specific polygenic risk scores (PRS), the              
usage of genetics alone for determining brain disease subtypes has been mostly elusive. One of the most                 
promising fields to pursue this aim, however, has been that of neuroimaging, with Magnetic Resonance               
Imaging (MRI) as arguably its most proficient method to date. This technique has been increasingly used to                 
study not only the structure of the brain (structural ​MRI​) but also to measure changes in the blood oxygen                   
levels surrounding particular regions, as a proxy of neuronal activation (​BOLD fMRI​) ​[14]​. One of the most                 
prevalent uses of this technology has been ​task fMRI​, in which an experimental design matrix is typically                 
convolved with a mathematical function modelling the haemodynamic response (called haemodynamic           
response function, or HRF) is set to explain the observed signal using a General Linear Model (GLM). While                  
this approach has a substantial amount of literature behind and it is highly flexible due to relying on a Linear                    
Model assumption ​[15]​, it has some notorious drawbacks. First, the most common analyses rely on what is                 
called a ​mass univariate test​, which statistically assesses differences in activation on each voxel separately,               
assuming independence even among contiguous regions in space. Second, it depends on a task              
experimental design, which even though it can be a powerful tool for answering specific questions is                
relatively hard to perform, difficult to generalise, and prone to habituation ​[16]​. An alternative that gained                
momentum over the last two decades has been ​resting-state ​fMRI, in which no particular task is performed                 
by the subjects. Since it was first employed in 1995 ​[17]​, this approach allowed researchers to study the                  
relationship between brain regions over time, which has been proven to be a useful tool to study both                  
functional connectivity (based on voxel correlation, yielding ​undirected connectivity networks) and ​effective            
connectivity (based on causal modelling, yielding ​directed connectivity networks). Regardless of the analysis             
tool, most studies largely converged in reporting multiple robust resting-state networks across the brain, such               
as the primary sensorimotor network, the primary visual network, frontoparietal attention networks and the              
well-studied default mode network ​[18]​. Furthermore, the idea of the brain having stable connectivity              
between its different regions that can be altered in illness has been a powerful hypothesis for disease                 
subtyping. Given its potential generalisability and the robustness of the obtained results ​[18,19]​, resting-state              
connectivity is currently the most used fMRI approach for both searching for and validating distinct               
mechanisms underlying brain disease, in an attempt of explaining the vast aforementioned heterogeneity. 
 
Unsupervised Machine Learning on psychiatric disease subtyping 
Automated pattern recognition can be used to unveil subtypes in psychiatric disease in an unsupervised               
way (that is, without the presence of hardcoded labels). Given the complexity of the data at play, this set of                    
approaches has been proven extremely useful in a variety of settings and data domains not only for                 
clustering but also for ​dimensionality reduction​. While the former deals with the process of finding subtypes                
in itself, the latter encapsulates a set of methods to project the data into lower-dimensional manifolds while                 
retaining most of its original information. In the case of functional MRI, unsupervised machine learning has                
been extensively important given the inherent absence of structure in the data. Its main uses include but are                  
not restricted to ​parcellation of the brain into discrete functional subunits (unravelling of brain              
connectivity networks), the study of ​brain connectivity dynamics (how those networks evolve over time),              
and ​grouping subjects according to their connectivity features ​(used for disease subtyping in itself). The               
first two mentioned uses fall into the dimensionality reduction category; the third is inherent to clustering.  
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This review will analyse the reported use to date of fMRI for unveiling subtypes in several psychiatric                 
disorders, as well as as a tool for validating subtypes reported in symptom scores and structural MRI. The                  
strengths and weaknesses of each approach will be discussed. For a detailed review of the existing                
unsupervised learning methods for disease subtyping, see Marquand at al (2016) ​[20]​. For methods on               
resting-state fMRI in particular, refer to Khosla et al (2019) [18]. 
 
Materials and Methods 
 
For consistency with previous work, this study followed the Preferred Reporting Items for Systematic              
reviews and Meta-Analysis (PRISMA) statements ​[21]​. 
 
Search methods for article retrieval 
A systematic search of original articles was carried out on the PubMed database, including all non-review                
articles from the date of database creation up to 25 May 2020. The string ​"(unsupervised learning OR                 
clustering OR dimensionality reduction OR subtyping) AND functional MRI" was introduced on the             
search engine, with the intention of retrieving all available papers in which functional MRI was used either for                  
brain disease subtyping or for validation of brain disease subtypes obtained via other methods, which should                
include at least one of symptom information and structural MRI data. 
 
Article filtering 
All retrieved studies were downloaded and analysed using PubMed metadata to filter review articles              
("D016428:Journal Article", but "D016454:Review" absent in the ​'publication_types' metadata field). The           
remaining studies were analysed using the ASReviews (Automatic Systematic Reviews) python package, an             
active learning based recommender system that trains a classifier on the abstracts of the provided papers, in                 
order to present the user with the most relevant papers to review. While all abstracts included in this step                   
were carefully studied, this tool has proven to be useful for prioritisation. Studies whose abstracts met the                 
exclusion criteria (see below) were discarded. The rest was selected for full-text review. 
 
Inclusion/exclusion criteria 
All original non-review studies in which functional MRI was used either for brain disease subtyping directly                
or for validation of brain disease subtypes obtained via other methods, which should include at least one of                  
symptom information and structural MRI data. Disease subtyping had to be carried out in a fully                
unsupervised way (no labels based on prior information). Clear definitions of the methods and their validation                
had to be included. As, given the heterogeneity of results, we think that cluster validation is currently one of                   
the most important discussion topics in the field, articles trying to replicate or validate the results of included                  
studies were also included. 
 
Data extraction for systematic analysis 
For each article that was included in the final review, a set of systematically collected pieces of                 
information was extracted and added as an entry to a table (see tables 1, 2, 3). This information includes: (a)                    
Publication year​, (b) Title, (c) ​Implicated brain disease​, (d) ​sample size​, (e) presence of              
preprocessing/dimensionality reduction, (f) ​clustering technique employed​, (g) ​cluster-number selection         
procedure​, (h) Healthy Controls included in the subtyping procedure​, (i) ​presence-of-clusters statistical            
testing (against continuum)​, and (j) ​data employed . 1
 
 
 
 
1 Given that fMRI data can be used for either validation of symptom clusters, validation of biomarker 
clusters or subtyping itself. 
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Results 
 
A total of 144 related articles were retrieved from PubMed in the first place, of which 120 were retained                   
after filtering for duplicated studies and reviews. 2 studies identified through manual search were also               
included, yielding a total of 122 articles selected for abstract inspection. During the aforementioned              
ASReview assisted procedure, a total of 35 articles were selected for a full inspection. The final number of                  
studies that met the inclusion criteria was 20. A scheme of the full pipeline is shown in Figure 1. 
 
 
 
 
Fig.1. ​PRISMA flowchart that    
schematizes the employed   
pipeline. A total of 144 articles      
were retrieved from PubMed using     
the string "​(unsupervised learning    
OR clustering OR dimensionality    
reduction OR subtyping) AND    
functional MRI​", and 2 articles were      
included after manual search,    
yielding a total of 146 input studies.       
After several systematic filters,    
which included exclusion of    
reviews, duplicated articles and    
relevance to the defined inclusion     
criteria, a total of 20 articles was       
included in the review. 
Light blue nodes indicate article     
input. Yellow nodes indicate    
filtering procedures. Light red    
nodes indicate discarded articles.    
Light green nodes indicated    
accepted articles during   
intermediate steps. The final green     
node indicates the accepted    
articles after the implementation of     
the whole pipeline.  
 
 
 
 
 
 
 
Characteristics of the included studies 
As previously mentioned, 20 full-articles were included in this review after the implementation of the               
specified pipeline. These studies were classified into one of three categories based on the nature of the                 
analysed subtypes and the usage of functional MRI (Figure 2). The classes are: (a) ​fMRI used for validation                  
of subtypes obtained via unsupervised learning of symptom-related data​, (b) ​fMRI used for validation of               
subtypes obtained via unsupervised learning of biomarkers other than fMRI (including structural MRI)​, and              
(c) ​fMRI used for brain disease subtyping directly​. Over the next three sections we will analyse these three                  
cases separately, summarising the results that the respective studies report, and discussing the assumptions              
they make and the advantages and disadvantages that they imply. 
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Regarding the pathological entities under study, the majority of the articles analysed patients diagnosed              
with ​Major Depression Disorder and ​Schizophrenia (38.1% and 28.6%, respectively. ​Psychosis​,           
Attention Deficit Hyperactivity Disorder​, ​Autism Disorder and consequences of ​early violence were            
also included. 
 
 
 
 
Fig.2. (A) ​Doughnut plot representing the number of selected studies for each of the three defined categories: (a) ​fMRI                   
used for validation of subtypes obtained via unsupervised learning of symptom-related data​, (b) ​fMRI used for                
validation of subtypes obtained via unsupervised learning of biomarkers other than fMRI (including structural MRI)​, and                
(c) ​fMRI used for brain disease subtyping directly. ​(B) Doughnut plot representing the most prevalent brain disorders                 
that the included studies analysed. 
 
 
fMRI used for validation of subtypes obtained via unsupervised learning of symptom-related data 
The first category to analyse corresponds to articles in which clusters were defined from              
symptom-based scales and functional MRI was employed as a tool for cluster interpretation and/or              
validation.  
The unsupervised classification of psychiatric symptoms is not new: to our knowledge the first papers               
were published back in the 1970s ​[10–12]​. The novelty of the studies presented here relies on the efforts                  
for interpreting and validating symptom clusters in terms of functional mechanisms. By comparing             
functional MRI data coming from patients on different clusters, researchers can potentially explain which              
mechanisms may be at play when yielding distinct sets of symptoms. After the systematic screening, five                
original studies covering both Major Depression Disorder and Schizophrenia fell into this section. In the               
following paragraphs, they will be discussed, ordered by disease. 
Taubner et al ​[22]​, analysed a small cohort of 20 subjects using Q factor analysis on SWAP-200 ​[23]                  
symptom data. Using an elbow method on the variance explained by PCA, they fit a two-factor model that                  
yielded two distinct patient types, defined by depressive personality and emotional-hostile externalising            
personality. A whole-brain correlation analysis was performed between the loadings of each factor and the               
GLM betas fitted to fMRI data, obtained during a stress-related task. While no correlation was significant for                 
factor 1, factor 2 yielded significant results in four regions: the right orbitofrontal cortex, the left ventral                 
striatum, the left temporal pole and the right middle frontal gyrus. While the sample size is small and the                   
proceedings arguably simple, the study calls itself a hypothesis-generating experiment that might be             
followed up in the future. 
A different approach, with bigger sample size, was employed by Maglanoc et al in 2018 ​[24]​. Using a                  
subspace clustering variant of Gaussian Mixture Models, the authors found five clusters of both major               
Miranda, L; Paul, R; Pütz B; Müller-Myhsok, B   6 
Functional MRI applications for psychiatric disease subtyping: a review 
depression patients and healthy controls in data coming from Beck's depression and Beck's anxiety              
inventories. They explored the relationship between symptom occurrence in each cluster and both static              
and dynamic functional connectivity matrices obtained from resting-state fMRI using ANCOVA. While there             
were no significant results from the dynamic connectivity analysis, there were significant correlations             
between the most severe depression cluster and the frontotemporal network. 
The rest of the studies in this section focused on Schizophrenia. The first, published by Geisler et al. in                   
2015 ​[24,25]​, aims to obtain subtypes not from symptoms directly but from a behavioural and cognitive                
score that they claim to be more longitudinally stable than standard symptom collections. Using a sample                
size of 129 patients and 165 healthy controls (not used for clustering), they derived four clusters using                 
K-means on an 8 dimensional PCA obtained from the behavioural and cognitive data. Both the number of                 
components for PCA and the number of clusters for K-means were obtained using an elbow method on the                  
variance explained and inertia curves, respectively. The clusters were characterised by a specific pattern of               
structural brain changes in areas such as Wernicke's area, lingual gyrus and occipital face area, and                
hippocampus as well as differences in working memory-elicited neural activity in several frontoparietal brain              
regions. The latter was assessed using functional MRI obtained during a blocked SIRP task. 
In 2018, Dickinson and colleagues published an article ​[26] in which they attempted to take a different                 
approach, by clustering data coming from the Positive And Negative Syndrome Score (PANSS), a              
widely-used standardised schizophrenia-specific symptom scale. Using a sample size of 549 individuals            
comprising only diagnosed patients and the 2-step SPSS clustering algorithm, they obtained three clusters              
that were characterised as deficit (with enduring negative symptoms and diminished emotionality), distress             
(with high emotionality, anxiety, depression and stress sensitivity) and low-symptomatic. A subsample of             
182 patients was exposed to functional MRI scans during a working memory task. When comparing the                
activations between the already defined clusters, statistically significant differences emerged in primary            
regions of the frontoparietal working memory network including right dlPFC, left anterior cingulate and left               
parietal cortex. The low-symptom subgroup showed significantly greater activation in the right dlPFC during              
working memory performance than the two more symptomatic groups, a “healthier” pattern of prefrontal              
engagement during the performance. 
 
 
 
Table 1: ​Retrieved articles in which fMRI was used to interpret symptom-based clusters 
Publication 
year 
Title Pathology sample size 
(symptoms) 
sample 
size 
(fMRI) 
data 
Preprocessing / 
Dimensionality 
reduction 
Clustering Model 
selection 
Healthy 
Controls 
included 
Stability 
testing 
Continuum 
testing 
Subtypes 
found 
2013 
Neural activity in relation to 
empirically derived personality 
syndromes in depression using 
a psychodynamic fMRI 
paradigm 
Major 
Depression 20 20 
SWAP-200, task 
fMRI 
Whole brain 
correlation 
between task 
and GLM betas 
Q-Factor 
analysis PCA No 
Not 
specified No 2 
2015 
Brain structure and function 
correlates of cognitive 
subtypes in schizophrenia 
Schizophrenia 294 294 
longitudinally 
stable cognitive 
scales, sMRI, 
fMRI 
PCA K-means 
Inertia 
elbow 
method 
Yes Not 
specified 
Yes (in 
model 
selection) 
4 
2018 
Attacking Heterogeneity in 
Schizophrenia by Deriving 
Clinical Subgroups From 
Widely Available Symptom 
Data 
Schizophrenia 549 182 
PANSS scale, 
task fMRI No 
SPSS 
2-step 
clustering 
BIC No Bootstrap 
Yes (in 
model 
selection) 
3 
2018 
Data-driven clustering reveals 
a link between symptoms and 
functional brain connectivity in 
depression 
Major 
Depression 
1084 251 BDI, rs fMRI No subspace 
GMM 
BIC Yes 
Jaccard 
index 
stability 
Yes (in 
model 
selection) 
5 
2020 
Neurobiological divergence of 
the Positive and Negative 
Schizophrenia subtypes 
identified on a new factor 
structure of psychopathology 
using non-negative matrix 
factorization: an international 
Machine Learning study 
Schizophrenia 1545 84 PANSS, rs fMRI 
Non-negative 
Matrix 
Factorization 
fuzzy-c 
means / 
GMM 
fuzzy 
silhouette 
index / 
BIC 
No 
leave-one
-site out 
CV, 
bootstrap 
Yes (in 
model 
selection) 
4 
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A similar approach was followed by Chen et al. in 2020 ​[26,27]​. Using a bigger sample of 1545 patients                   
diagnosed with schizophrenia, they used Non-Negative Matrix Factorization to reduce the dimensionality of             
patients' PANSS score data. The optimal value of four factors was obtained using cross-validation after               
10.000 split-half runs on the Rand index, VOI (variation of information index) and the concordance index                
between dictionaries. These factor loadings were used as input for clustering using the fuzzy-c-means              
algorithm, assisted by Gaussian Mixture Modelling to delimit the threshold between clusters. 
The optimal cluster number was determined using the fuzzy silhouette index among others, and cluster               
stability was addressed via leave-one-site out replication, subsampling and bootstrap. Regarding MRI,            
functional undirected connectivity was obtained from resting-state data, and the extracted networks were             
used to predict cluster membership in a supervised manner using an RBF Support Vector Machine. A                
feature importance analysis of this classifier yielded profiles of the ventromedial frontal cortex,             
temporoparietal junction, and precuneus as the most important networks for cluster assignment. 
 
fMRI used for validation of subtypes obtained via unsupervised learning of biomarker data 
In this second section, we will discuss three studies (published across four papers) in which the obtention                 
of biotypes was attempted applying unsupervised learning techniques to sets of biomarkers other than              
functional MRI itself. Among the included biomarkers, one of particular interest is structural MRI, for which                
the necessary assumptions underlying structure and function will be discussed in the following paragraphs. 
The first study is composed of two articles, published by Clementz et al and Meda et al in 2015 and 2016                     
[28]​,​[29] on the identification of psychosis biotypes. The first article deals with the objection of the biotypes                 
themselves, the second analyses their functional correlates using resting-state functional connectivity.  
The term psychosis refers to the general concept applied to several pathologies that lead to a                
deteriorated perception of reality. The authors of this study claim that there may be different aetiologies                
underlying psychotic symptoms that do not necessarily overlap with the symptom-defined labels available             
(schizophrenia, schizoaffective disorder, and bipolar disorder with psychosis). They gathered 1872 samples            
from patients diagnosed with any of these diseases (n=711), their first-degree relatives (n=883) and              
comparable healthy subjects (n=278). The data consisted of biomarker panels comprising           
neuropsychological markers, stop-signal data, saccadic control data and auditory stimulation paradigms.           
Patient data were used for clustering, while relatives and controls served for result interpretation. The data                
were first processed using the pre-clustering step of the SPSS 2-step clustering algorithm to obtain a                
nine-dimensional feature space that they fed into a K-means algorithm for finding the biotypes. The number                
of clusters was selected using the gap statistic, yielding a three-component solution that did not overlap with                 
the DSM-5 defined labels mentioned above. They hypothesized that these three components may             
correspond to three different aetiologies, that over the patients' lifespan lead to similar sets of symptoms, and                 
observed that clusters differed in outcome severity, cognition measures and sensorimotor reactivity, among             
others. 
In the follow-up study, individuals in an independent sample were assigned to the already defined               
clusters, and comparisons between their ICA obtained functional resting-state connectivity profiles were            
made by means of linear mixed models for within-proband differences across categories and correlations              
with the aforementioned biological profile scores. They claim that their biotypes performed marginally better              
in terms of separating out psychosis sub-groups from their functional connectivity data compared to              
conventional DSM-5 diagnosis. When comparing patients to relatives and healthy controls, they found             
significantly reduced connectivity on specific biotypes in nine networks, including the cuneus-occipital            
network, the left and right FPN networks, the cerebellar occipital network, the anterior, IP and SP default                 
mode networks, the temporoparietal network, and the frontoparietal control network. All these deficits are              
claimed to track more closely with cognitive control factors, suggesting potential implications for both              
disease profiling and therapeutic intervention. 
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The remaining two studies, published by Chen et al in 2019 ​[30] and Kaczkurkin et al in 2020 ​[31]​, used                    
structural MRI to find disease subtypes and projected their findings into resting-state functional connectivity              
data afterwards. 
The first of the two attempts to find Autism Disorder subtypes in a sample of 759 individuals comprising                  
both patients and healthy controls. After using Non-negative Matrix Factorization to reduce the             
dimensionality of a Voxel-Based Morphometry analysis of the structural data, clustering was performed using              
the K-means algorithm. Using the silhouette index for model selection, the analysis yielded a              
three-component solution, which they claim confirms that ASD is not a neuroanatomically homogeneous             
disease. When comparing the obtained clusters with both symptomatic scores, they found that clusters              
showed differences in disease severity. When comparing the resting-state functional connectivity networks            
obtained with the ​data processing assistant for resting-state fMRI tool (DPARSF) ​[32] in each cluster to                
healthy controls, they found statistically significant differences in two of the clusters. ASD patients had               
diminished connectivity in the default mode network, the frontoparietal network, the cingulo-opercular            
network and the occipital network. 
The second work, focused on finding structural subtypes in subjects with internalising disorders, takes a               
particular approach to disease subtyping. Instead of clustering in a fully unsupervised way, the authors use a                 
semi-supervised approach called HYDRA ​[33] which uses the binary disease-control labels to find different              
disease subtypes regarding their difference to controls. To achieve this they employ a multiple linear SVM                
classifier under the hood that both maximizes the margin between cases and controls for each cluster and                 
the margin between clusters. Using this algorithm in volumetric and cortical thickness data coming from 1141                
individuals, they found a two disease-cluster solution when maximising the adjusted Rand index (ARI) during               
cross-validation. When analysing both structural particularities of the subject belonging to each cluster, as              
well as symptomatic and cognitive measures, the authors found that one of the subtypes showed smaller                
volume, thinner cortex, reduced white matter integrity, greater psychopathology and poorer cognitive            
performance than its counterpart. The functional connectivity of 40 subjects assigned to these two defined               
categories was obtained in the frequency space, by computing the voxelwise amplitude of the low-frequency               
(0.01-0.08 Hz) band of the power spectrum (ALFF). This approach has the advantage of allowing the direct                 
comparison of structural and functional measures using the same atlas ​[34]​, the functional measures being a                
reflection of the average connectivity of a particular region of interest, in this case, delimited by differential                 
structural measures. Using this approach, the authors found significant differences in average connectivity             
between clusters in frontal regions, the right amygdala and the right hippocampus, which correlated with               
poorer function across multiple domains. They claim that the identification of biologically grounded             
internalising subtypes may assist in targeting early interventions and assessing longitudinal prognosis. 
 
Table 2:​ Retrieved articles in which fMRI was used to interpret biomarker-based clusters  2
Publication 
year 
Title Pathology sample size 
(biomarkers) 
sample 
size 
(fMRI) 
data 
Preprocessing / 
Dimensionality 
reduction 
Clustering Model 
selection 
Healthy 
Controls 
included 
in 
clustering 
Stability 
testing 
Continuum 
testing 
Subtypes 
found 
2015 
Identification of Distinct 
Psychosis Biotypes Using 
Brain-Based Biomarkers 
Psychosis 1872 - biomarkers 
SPSS pre 
clustering k-means 
gap 
statistic No No 
Yes (in 
model 
selection) 
3 
2016 
Examining Functional Resting 
State Connectivity in Psychosis 
and its subgroups 
Psychosis 1125 1125 
symptoms, 
rs fMRI 
Functional 
connectivity (ICA) - - - - - - 
2019 
Parsing brain heterogeneity in 
males with autism spectrum 
disorder reveals distinct clinical 
subtypes 
Autism 
Disorder 
759 403 
sMRI, 
symptoms, 
fMRI 
Non-negative 
Matrix 
Factorization 
K-means silhouette 
index 
No Bootstrap No 3 
2020 
Neurostructural Heterogeneity 
in Youths With Internalizing 
Symptoms 
Internalizing 
disorders 1141 40 
sMRI, 
symptoms, 
fMRI 
knowledge-based 
feature selection HYDRA 
Stability 
based 
(Adjusted 
Rand 
Index) 
Yes 
Adjusted 
Rand 
Index, 
cross 
validation 
No 2 
2 The first two articles in the table are complementary. Whilst the first provides the biomarker clustering, the second contributes 
with a functional MRI interpretation of the same analysis, hence they are both included. 
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fMRI used for brain disease subtyping directly 
The last results section will deal with studies in which biotype obtention was attempted from functional                
MRI data itself. Eleven articles (ten original studies and a very relevant replication) comprising four disorders                
were included, ten of which relied on resting-state functional or effective connectivity. The implications of               
each methodology will be discussed after an overview of each individual work. 
Starting with Schizophrenia and its related disorders, in 2014 Yuhui Du et al published an article in which                  
the distinction between Schizophrenia, Schizoaffective disorder and psychotic bipolar disorder, all of which             
share a common set of symptoms, was attempted to be redrawn using functional connectivity data clustering                
[35]​. They employ Group Information Guided ICA (GIG-ICA) ​[36] to obtain subject-specific functional             
connectivity networks from a sample of 93 individuals containing patients diagnosed with any of the               
mentioned pathologies as well as healthy controls. For each subject, a vector was constructed with the                
connectivity features that remained after an SVM recursive feature elimination procedure ​[37]​, and an              
interindividual distance matrix was constructed using the inverse of Pearson's correlation coefficient. All three              
of K-means, n-cut and Hierarchical Agglomerative Clustering were used with K=5, and the accuracy in               
retrieving the original groups was assessed. During feature selection, regions such as the default mode               
network, frontoparietal networks, salience networks, auditory-related network, parietal network, vision and           
visuospatial networks, cerebellum and sensory-motor networks were prioritised, indicating that the           
connectivity among these regions may be of interest for distinguishing between the pathologies at hand.               
While this study did not delve into the discovery of new subtypes of a predefined disease, it provided                  
connectivity evidence for the distinction and validation of distinct disease entities whose symptoms overlap,              
adding fresh evidence to an ongoing discussion in the field. 
Another article that dealt with dissecting the mechanistic underpinnings of Schizophrenia and its potential              
subtypes was published by Brodersen et al in 2014 ​[38]​. In this proof-of-concept study, the authors employed                 
a dynamic causal modelling algorithm to retrieve a directed connectivity model from a sample of 83 subjects                 
including diagnosed patients and healthy controls. By employing a variational Bayesian variant of a Gaussian               
Mixture Model-based clustering algorithm in the DCM parameters, the authors were able to retrieve a three                
cluster solution from the patients alone, whose components significantly differed in their clinical             
manifestation, as assessed by the aforementioned PANSS scale. When including the healthy controls,             
however, the best-found solution (the one with the lowest BIC score) had only two components that                
overlapped ~72% with the case/control labels. The authors use these results as an argument to defend the                 
exclusion of healthy controls in the unsupervised learning procedure, as the likelihood of the already-known               
binary factor is high. 
The last covered article on (early onset) Schizophrenia subtyping was published by Yang et al, also in                 
2014 ​[39]​. Using a small sample of 52 individuals including both diagnosed patients and healthy controls, the                 
authors used a pipeline called gRACIAR (​generalized ranking and averaging independent component            
analysis by reproducibility​) ​[40] to obtain both subject-specific functional connectivity networks and a meta              
graph concerning intersubject similarity. Using Newmann's community detection algorithm with          
cross-validated binarizing thresholds, they obtained a two-component solution whose clusters were           
differentiable by means of the PANSS scale. Furthermore, a feature importance analysis revealed the crucial               
importance of the precuneus angular gyri, the superior temporal gyri and the inferior frontal gyri for                
early-onset schizophrenia biomarking. 
Drysdale et al in 2017 ​[41] used a Canonical Correlation Analysis (CCA) to reduce the dimensionality of                 
resting-state functional connectivity data coming from a sample of 312 patients diagnosed with MDD, in a                
way that maximized its correlation with symptom data coming from HAM-D scores. While this approach can                
be useful for integrating the two types of data, conclusions derived from it must be taken with caution: a                   
transformation of the biological data that correlates with the final phenotypic outcome could shed light into                
biological markers to identify those phenotypes in a less subjective way than a questionnaire, but their                
correspondence to biotypes or distinct aetiologies, as previously mentioned, can be questioned. The authors              
then used the first two canonical variates obtained from CCA (which they interpreted as anhedonia and                
anxiety-related) to cluster individuals and reached a four-component solution using a Hierarchical            
Agglomerative Clustering approach. When projecting the obtained clusters into the original resting-state            
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connectivity data, differential activations were observed in the limbic and frontostriatal networks. In addition,              
they reported that cluster membership accurately predicted treatment response, as assessed via HAM-D             
evaluation during and after Transcranial Magnetic Stimulation treatment. 
While ambitious and inspiring, this article received strong criticism in a replication attempt made by Dinga                
et al in 2019 ​[42]​. While following nearly the same pipeline on a smaller independent cohort of 187                  
individuals, the authors highlighted several statistical weaknesses in the original study. First, they claim that               
there is a bias in the statistical testing of the CCA results in the article published by Drysdale et al. While the                      
original article reports that both canonical variates' correlation with symptoms is statistically higher than              
random, permutation testing in the replication study showed that this seems not to be the case when taking                  
into account the pre-selection of voxels that were most correlated with the symptoms themselves. Dinga et al                 
claim that the original procedure is likely to be selecting noise in the direction of the hypothesis, and not                   
correcting the consequent statistical tests afterwards. 
 
Table 3: ​Retrieved articles in which fMRI was used to cluster subjects into biotypes 
Publication 
year 
Title Pathology 
sample 
size 
(fMRI) 
data 
Preprocessing / 
Dimensionality 
reduction 
Clustering Model selection 
Healthy 
Controls 
included 
Stability 
testing 
Continu
um 
testing 
Subtypes 
found 
2014 
Exploring difference and 
overlap between 
schizophrenia, schizoaffective 
and bipolar disorders using 
resting-state brain functional 
networks 
Schizophrenia, 
Schizoaffective 
disorder, bipolar 
disorder 
93 rs fMRI 
Functional 
connectivity 
(GIG-ICA) 
k-means, n-cut, 
HAC 
No Yes No No 5 
2014 
Dissecting psychiatric 
spectrum disorders by 
generative embedding 
Schizophrenia 83 rs fMRI 
Effective 
connectivity (DCM) 
Variational 
Bayesian GMM 
(on 
connectivity 
parameters) 
BIC Yes/No No 
Yes (in 
model 
selection) 
2/3 
2014 
Organizing Heterogeneous 
Samples Using Community 
Detection of GIMME-Derived 
Resting State Functional 
Networks 
ADHD 80 rs fMRI 
Effective 
connectivity 
(GIMME) 
Newmann's 
Graph-based 
Community 
Detection 
Reachability-based 
thresholding Yes Bootstrap No 5 
2014 
Brain network informed 
subject community detection 
in early-onset schizophrenia 
Schizophrenia 52 rs fMRI 
Functional 
connectivity 
(gRACIAR) 
Newmann's 
Graph-based 
Community 
Detection 
Reachability-based 
thresholding 
Yes Bootstrap No 2 
2015 
Characterizing heterogeneity 
in children with and without 
ADHD based on reward 
system connectivity 
ADHD 106 rs fMRI 
Neurosynth meta 
analysis, Functional 
connectivity 
Newmann's 
Graph-based 
Community 
Detection 
Reachability-based 
thresholding 
Yes Permutation 
VOI 
No 3 
2017 
Resting-state connectivity 
biomarkers define 
neurophysiological subtypes 
of depression 
Major 
Depression 
312 rs fMRI, 
HAM-D 
Canonical 
Correlation Analysis 
Hierarchical 
Agglomerative 
Clustering 
Maximum ratio of 
between-cluster to 
within-cluster variance 
No No No 4 
2017 
Data-Driven Subgroups in 
Depression Derived from 
Directed Functional 
Connectivity Paths at Rest 
Major 
Depression 80 rs fMRI 
Effective 
connectivity 
(GIMME) 
Walktrap 
Graph-based 
Community 
Detection 
Handled by the 
clustering algorithm No 
Based on 
random 
perturbations of 
the similarity 
matrix 
No 2 
2018 
Brain-behaviour patterns 
define a dimensional biotype 
in medication-naive adults 
with attention-deficit 
hyperactivity disorder 
ADHD 203 
rsfMRI, 
behavioural 
data 
Canonical 
Correlation Analysis 
(NBS, behavioural 
data) 
k-means/ 
spectral 
clustering 
Silhouette, Jacquard, 
GAP / similarity 
threshold perturbation 
Yes No Yes 1 
2018 
Identification of depression 
subtypes and relevant brain 
regions using a data-driven 
approach 
Major 
Depression 
134 
rsfMRI, 
BDI, SNPs, 
Methylation, 
biomarkers 
Functional 
connectivity 
Multiview 
co-clustering 
Best view in separating 
cases and controls 
(Cohen's D) 
Yes 
Multiple 
random 
initializations 
No 5 
2019 
Evaluating the evidence for 
biotypes of depression: 
Methodological replication 
and extension of Drysdale et 
al. (2017) 
Major 
Depression 187 
rs fMRI, 
IDS 
Canonical 
Correlation Analysis 
Hierarchical 
Agglomerative 
Clustering 
- No 
Jackknife 
analysis Yes 1 
2020 
Biotypes of functional brain 
engagement during emotion 
processing differentiate 
heterogeneity in internalizing 
symptoms and interpersonal 
violence histories among 
adolescent girls 
Early violence 114 task fMRI 
Neurosynth meta 
analysis, GLM 
parameters 
k-means Inertia elbow method Yes 
Jackknife 
analysis 
Yes (in 
model 
selection) 
3 
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In addition, they mention that even when doing a proper model selection procedure, the original study                
does not test the hypothesis that there is an inherent clustering structure in the data, against the possibility of                   
a continuum. When testing this using previously described methods ​[43]​, they find no significative evidence               
supporting clustering. While some details of the proceedings were not the same, such as the symptom scale                 
used or some differences in fMRI preprocessing, this article shows how important proper statistical testing is                
in these complex scenarios of multiple data integration and how crucial replication attempts are. 
While all studies mentioned in this section so far dealt with data coming from resting-state ​functional (and                 
thus undirected) connectivity, Price et al were the first to our knowledge, in 2017, to use ​effective ​connectivity                  
to build directed resting-state networks using causal modelling for brain disease subtyping ​[44]​. The              
algorithm employed for graph construction (called Group Iterative Multiple Model Estimation, or GIMME) has              
been extensively shown to reliably recover both the presence and direction of connectivity among brain               
regions per individual in simulations. Using a sample of 80 diagnosed patients with Major Depression, the                
authors built a meta-network based on the correlations between model parameters among individuals, where              
the linking thresholds were controlled using statistical testing based on network random perturbation.             
Applying a Walktrap community detection algorithm in this meta-graph yielded a two-component solution,             
whose stability was tested by perturbing the graph as well. The biggest group showed a typical connectivity                 
pattern across DMN nodes, as previously reported on average depressed patients. The smaller group,              
however, showed atypical connectivity in this region, with increased dorsal anterior cingulate-driven            
connectivity paths. This smaller group had also significantly higher comorbidity with an anxiety disorder and               
highly recurrent depression, which lead to a poorer outcome of the disorder. While the employed sample size                 
is small, this study illustrates how graph theory and causal modelling can be used together to shed light into                   
the mechanisms behind major depression in particular and brain disorders in general. 
Continuing with MDD, a very different unsupervised approach was taken by Tokuda et al in 2018 ​[45]​.                 
The authors of this article employed a custom made co-clustering algorithm capable of grouping both               
features and subjects, yielding multiple subspace solutions, or ​views​, that can explain multiple grouping              
structures present in the data. While some might be irrelevant to the problem at hand (such as age or sex),                    
by selecting the ​view that correlates the most with pre-accepted labels (e.g. that separates cases and                
controls the most accurately) it is possible to retrieve a relevant clustering solution and feature selection on                 
the same step. Furthermore, this method allows the authors to integrate resting-state functional connectivity              
data with other data domains, such as BDI questionnaires, biomarker panels, and genetics and methylation               
data coming from a preselected set of related genes. They used this approach to cluster a sample of 134                   
subjects including both patients and controls and selected the ​view with the greatest Cohen's D coefficient                
when separating cases and controls. The algorithm yielded a five-component solution, of which two              
corresponded to controls and three to patients almost exclusively. The three MDD-related reported clusters              
were observed to differ significantly by functional connectivity between the Angular Gyrus and other brain               
areas in default mode networks, child abuse trauma scale scores (CATS) and selective serotonin reuptake               
inhibitor treatment outcomes. While the employed sample size is relatively small and the results demand               
replication, this article proposes an innovative and powerful approach with a high potential for integrating               
distinct data domains. 
The first article to mention attention deficit hyperactivity disorder (ADHD) was published in 2014 by Gates                
et al ​[46]​. Using the aforementioned GIMME algorithm to recover directed connectivity graphs from a sample                
of 80 individuals including both diagnosed patients and healthy controls, the authors applied Newmann's              
community detection to a meta-network based on intersubject connectivity correlation to retrieve a solution              
with five components whose stability was evaluated via bootstrapping. While the obtained subgroups are              
highly distinguishable by their differential connectivity in regions such as the dorsolateral prefrontal cortex,              
the frontal cortex, the intraparietal sulcus, and the inferior parietal lobule, the presence of both cases and                 
controls in each of the clusters makes it difficult to analyse how clinically relevant the reported structure can                  
be. The study, however, serves as a proof of concept for the highly standardised pipeline it proposes and                  
opens the discussion for further exploration. 
Using a functional connectivity pipeline on a sample of 106 children (aged 7-12 years) including both                
diagnosed patients and controls, Costa Dias et al also attempted to find data-driven subtypes of ADHD in                 
Miranda, L; Paul, R; Pütz B; Müller-Myhsok, B   12 
Functional MRI applications for psychiatric disease subtyping: a review 
their article published in 2015 ​[47]​. By means of a meta-analytic mask obtained from NeuroSynth ​[48] which                 
was centred on the reward system, the authors filtered the resting-state functional MRI time-series before               
feeding them to a correlation-based algorithm for connectivity extraction. A meta correlation matrix was              
obtained to assess interindividual similarities, and a three cluster solution was obtained using Newmann's              
community detection, which was stability tested by means of the Variation of Information (VOI index) under                
random network permutations. While all three subgroups contained both cases and controls, there were              
significant community-specific connectivity differences between patients and healthy subjects. Furthermore,          
impulsivity-related behavioural scores were significantly distinct between cases and controls only in one of              
the subgroups, indicating that the retrieved functional subgroups might be related to specific behavioural              
characteristics. 
A very different conclusion was reached by the last included article on ADHD, published by Lin et al in                   
2018 ​[49]​. The authors criticize previous efforts for both the inclusion of healthy controls in the clustering                 
sample and the lack of testing for the presence of a subgroup structure before applying the unsupervised                 
learning techniques. By contrasting what they called a dimensional biotype (a non-discrete severity             
continuum of the same pathological entity) against a categorical biotype, they claim that they lack evidence                
for the latter and that therefore clustering structures previously reported should be interpreted with caution.               
The methods they employ to reach these statements, however, are very different from the ones described                
before, making direct comparisons difficult. They obtain functional connectivity networks using an ICA based              
pipeline and compute the Network-Based statistic for every diagnosed patient (n=80) and matched control              
(n=123). Next, they compute the canonical correlations (CCA) between the NBS results and a set of                
symptoms assessed by factor scores of inattentive and hyperactivity-impulsivity symptoms and FIQ. When             
assessing the clustering structure both via K-means of the CCA results and spectral clustering of the NBS                 
and the symptoms together, they do not find significant evidence backing more than one cluster (as                
assessed by the average silhouette index, the Jaccard similarity index and the GAP statistic, and the                
convergence of the number of clusters across different similarity thresholds, respectively). While their             
conclusions are valid when including the symptoms in the clustering process (either directly or indirectly via                
CCA), the analysis does not rule out, in our opinion, the possibility of several independent functional entities                 
behind a unique set of symptoms that can be interpreted as a continuum, and more research is needed to                   
solve this issue. 
The last paper in this section, published by Sellnow et al in 2020 ​[50]​, delves into the functional                  
consequences of violence in early childhood and internalising symptoms. Using a sample of 114 adolescent               
girls (aged 11-17), the authors used functional MRI obtained during an emotion processing task in a blocked                 
design. After filtering the voxels of interest using a meta-analytic mask obtained from NeuroSynth (related to                
emotion processing), the GLM first order betas were clustered using the K-means algorithm. After selecting               
the best model in terms of the elbow method on the cluster validity index they reached a three-component                  
solution, proven stable via leave-one-out cross-validation. The clusters were distinguishable by engagement            
of the medial prefrontal cortex, the anterior insula, the hippocampus, and the parietal and ventral visual                
cortex during emotion processing. When analysing the relationship between each cluster and measures of              
interpersonal violence (IPV) and internalised symptoms, the authors reported differential correlations per            
group. Furthermore, as IPV exposed a negative correlation with symptom reduction over Trauma-Focused             
Cognitive Behavioural Therapy (TFCBT), the authors explored the possibility of their methodology to predict              
treatment outcome based on functional information. 
 
Discussion 
 
This article reviewed the existent methodologies and approaches to employ functional MRI data in              
precision psychiatry, and more precisely in brain disease data-driven subtyping. A total of twenty articles               
were retrieved from the PubMed database after a systematic screening, in which fMRI was used either for                 
validation/interpretation of subtypes obtained from symptom or biomarker data clustering or for biotype             
obtention itself. 
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While the first section of the results provided examples that illustrate how powerful unsupervised              
learning can be to detect subgroups in psychiatric symptom data (table 1), it's important to keep in mind                  
several fundamental facts when using these tools. First, as discussed in the introduction, different sets of                
symptoms do not necessarily reflect distinct aetiologies. Second, symptoms are sensitive to treatment and              
environmental perturbations, among others. This may reflect in patients changing cluster assignments            
during the course of their disease, reflecting distinct symptomatic states over time. While the studies cited                
in this section do not particularly reflect that (with the exception of Geisler et al), there is a growing interest                    
in analysing longitudinal symptom clusters, not only to dissect putative causes of disease but also with the                 
aim of improving prognosis by building forecasting models ​[51]​. 
The second set of articles (table 2) focused on a very different approach. While, as discussed before,                 
symptom information can be extremely useful for subtyping patients due to the higher data availability and                
standardization of the recordings, the results do not necessarily correspond to biotypes and are not likely to                 
be stable over time, reflecting more disease states rather than entities. When clustering biomarkers,              
however, the assumption is that the data capture the manifestation of the disorder at a lower level, yielding                  
results that are potentially closer to uncovering pathological origins. To illustrate this claim with an example,                
there have been studies which show how different genetic alterations which produced different structural              
consequences, led to the same set of autistic-like behavioural traits in mice ​[52]​. 
Among the methodologies overviewed in this section, structural MRI clustering and its projection into              
functional data deserve special mentioning. Several studies have shown that psychiatry-related disorders            
have in many cases structural implications. While diseases such as Autism or Schizophrenia are generally               
recognised as neurodevelopmental disorders with brain structure being affected, there are inconsistencies            
regarding the regional specificity of the neuroanatomical findings, which make apparent the importance of              
structural subtyping. Furthermore, the search for functional correlates of these subtype-specific functional            
alterations relies on the assumption that an altered structure may lead to an altered function. By combining                 
the two data types, it is possible to test this hypothesis, retrieving multiple domains affected by the disorder                  
that may be coupled with a non-trivial causal relationship. 
The third and last set of articles (table 3) dealt with unsupervised learning on functional MRI itself, a                  
technique with the potential of shedding light into mechanistic biotypes reflecting distinct pathological entities              
that overlap at higher levels. While, on the interpretation side, this category is not substantially different from                 
the previous one, the distinction was made based on the usage that the researchers gave to the functional                  
MRI data itself. Both task and resting-state approaches have been explored, although the vast majority of                
studies opted for the latter given its easier implementation and potentially broader conclusions and              
generalisability. The employed pipelines were extremely variable, using both functional and effective            
connectivity and a broad collection of clustering algorithms, the simple K-means and graph theory-based              
methods being the favourite tools.  
Regarding testing of the presence of a cluster structure against a continuum in all three categories,                
several studies overlooked this issue completely, and most included K=1 as a possible cluster solution during                
model selection. Very few included dedicated statistical tests to evaluate the presence of clusters alone.               
Stability, however, was thoroughly tested in most of the articles, leave-one-out cross-validation and random              
network permutations (for graph-based systems) being the most employed methodologies. The sample            
sizes, however, remain mostly small and much more testing and replication is needed, especially concerning               
functional biotypes. 
In this regard, as MRI data has an extremely high number of features, dimensionality reduction               
techniques are nearly mandatory when the sample sizes are small. While there are several manners of                
narrowing the feature space, special mention goes to the ways of integrating external domain knowledge into                
the functional clustering pipelines, either by directed dimensionality reduction (using CCA or its related              
variants​[53]​, for example) or by the usage of meta-analytic masks for feature selection (such as the ones                 
provided by NeuroSynth). The former can be handy to gather functional correlates of expressed symptoms               
but has the downside of shifting the attention from the pure mechanistic biotype elucidation, most likely                
yielding clusters based on functional manifestations of phenomena that can be observed at a higher level. In                 
any case, proper statistical testing has to be carried out to avoid overfitting, to which several algorithms in                  
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this family are prone ​[54]​. Meta-analyses, for their part, are a simple way of selecting features that have                  
already been implicated in the disease at hand. While this can be useful to reduce the feature space and                   
extract potentially more meaningful conclusions, the study may lose information about brain areas not yet               
reported to be relevant, for example by being implicated in only a subset of the possible biotypes. 
To conclude, although functional MRI has a great potential in several areas of precision medicine such as                 
diagnosis, prognosis and treatment selection, the results achieved so far are inconsistent in all cases, and                
much remains to be done in terms of gathering and centralising data, standardising pipelines and model                
validation, and method refinement. Furthermore, as most of the presented studies started from             
symptom-defined broad labels (such as Major Depression or ADHD, for example), much remains to be               
explored in the field of trans-diagnostic data-driven psychiatry ​[55]​. The potential contribution of functional              
MRI to this field, that as mentioned in the introduction searches for a data-driven replacement for the current                  
canon DSM labels, remains vastly uncharted. 
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